Tebina 125mg Tablet DT
By Tebina
Rx
7 Tablet DT in a Strip

Composition
Terbinafine(125mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
August, 2025

liver
Tebina 125mg Tablet DT should be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of Tebina 125mg Tablet DT in such cases, so it is important to consult your doctor. This medication is not advisable for individuals with severe liver disease or those with active liver disease. If you experience any signs or symptoms of jaundice while using this medicine, inform your doctor promptly.

kidney
Tebina 125mg Tablet DT requires caution in kidney disease patients. Dose adjustment may be necessary. Consult your doctor.

alcohol
Caution is recommended when drinking alcohol with Tebina 125mg Tablet DT. It is best to consult your doctor about this interaction.

driving
Tebina 125mg Tablet DT may cause side effects that can impact your driving ability. It is advisable to be cautious while driving when taking this medication.

pregnancy
Tebina 125mg Tablet DT is generally safe during pregnancy based on animal studies showing minimal adverse effects on the developing baby. Limited human studies are available.

breastfeeding
Tebina 125mg Tablet DT may not be safe to use while breastfeeding as it can potentially pass into breastmilk and harm the baby. It is advisable to consult a doctor before using this medication.
Habit Forming | No |
Chemical Class | Allylamine |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Fungal ergosterol synthesis inhibitor |
₹104.5
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025